Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Yukihiko Matsuno is active.

Publication


Featured researches published by Yukihiko Matsuno.


Journal of the American College of Cardiology | 2000

Three minute, but not one minute, ischemia and nicorandil have a preconditioning effect in patients with coronary artery disease.

Tetsuo Matsubara; Shinya Minatoguchi; Hitoshi Matsuo; Kenji Hayakawa; Tomonori Segawa; Yukihiko Matsuno; Sachiro Watanabe; Masazumi Arai; Yoshihiro Uno; Masanori Kawasaki; Toshiyuki Noda; Genzou Takemura; Kazuhiko Nishigaki; Hisayoshi Fujiwara

OBJECTIVES This study focused on 1) the determination of the optimal preconditioning (PC) duration, and 2) the protective effect of nicorandil (NC), a hybrid nitrate with a KATP channel opening effect, during a percutaneous transluminal coronary angioplasty (PTCA) model in humans. BACKGROUND The ischemic PC effect is induced in 180 s ischemia, but not in 120 s ischemia in rabbit hearts. However, the duration of ischemia that induces PC effect and the role of the KATP channel in the PC effect in humans are still unclear. METHODS Forty-six patients with stable angina were randomly allocated to four groups: the duration of the first inflation as PC ischemia was 60 s in the PC60 group (n = 12), and 180 s in the PC180 group (n = 12). In the other groups, NC (80 microg/kg) was intravenously given for 1 min in the NC group (n = 12), and isosorbide dinitrate (ISDN) (40 microg/kg) was given in the ISDN group (n = 10). Five minutes after first inflation or drug administration, a second inflation was conducted for 120 s in each group. In the ECG, the lead with the largest shift in ST segment (deltaST max), and the sum of elevated ST levels in all leads (sigmaST) were determined. RESULTS In the PC60 group, no significant difference was observed in either deltaST max or sigmaST between the first and second inflation. However, the second inflation in the PC180 group showed significantly lower levels of deltaST max and sigmaST compared with those of the first inflation. In the NC group, both deltaST max and sigmaST measured at 30 s and 60 s after balloon inflation were significantly lower than those of the first inflation in the PC60 and PC180 control groups. In the ISDN group, no significant difference was observed in deltaST max or sigmaST. CONCLUSION In human PTCA models, a PC effect is observed in 180 s ischemia, but not in 60 s ischemia. A pharmacological PC effect is induced by NC, a KATP channel opener with a nitrate-like effect but not ISDN. This suggests that the opening of KATP channels plays an important role in the protecting effect of NC.


Annals of Nuclear Medicine | 1993

Assessment of area at risk and efficacy of treatment in patients with acute coronary syndrome using99mTc tetrofosmin imaging in humans

Hitoshi Matsuo; Sachiro Watanabe; Yoshio Nishida; Tetsuo Matsubara; Motoo Kano; Akira Sugiyama; Yukihiko Matsuno; Hiroshi Oda; Yasunori Kotoo; Hiroshige Oohashi; Akira Goto; Kazunari Makita; Hiroshi Watanabe; Taketoshi Mizutani; Hiroshi Miyake; Takeyoshi Imaeda

The determination of the myocardium at risk before intervention and the change in that region after intervention constitute a promising measurement tool for the assessment of acute therapy. A new99mTc labeled myocardial blood flow tracer,99mTc tetrofosmin, is expected to enable the evaluation of myocardium at risk because of the absence of redistribution. This preliminary study was performed in 9 patients with acute coronary syndrome (4 unstable angina and 5 acute myocardial infarction) to investigate whether recovery of perfusion by tetrofosmin imaging parallels mechanical improvement. Tetrofosmin imaging was performed acutely and 3–30 days later. Visual analysis of defect severity was assessed in both studies. Segments with improvement in perfusion were accompanied by significant wall motion recovery compared with normal and unimproved segments (Δ WMI: normal segments 0.40±0.67, improved segments 1.79±0.68, unimproved segments −0.15±0.16, p< 0.01 for improved segments compared with other groups), suggesting the efficacy of this tracer for the assessment of the acute therapy. These data suggest that99mTc tetrofosmin imaging is a useful method for the assessment of the myocardial area at risk and the efficacy of acute therapy in acute myocardial infarction and unstable angina.


Annals of Nuclear Medicine | 1994

Identification of asynergic but viable myocardium in patients with chronic coronary artery disease by gated blood pool scintigraphy during isosorbide dinitrate and low-dose dobutamine infusion: Comparison with thallium-201 scintigraphy with reinjection

Hitoshi Matsuo; Sachiro Watanabe; Yoshio Nishida; Tetsuo Matsubara; Motoo Kano; Shintaro Tanihata; Yukihiko Matsuno; Hiroshi Oda; Yasunori Kotoo; Hiroshige Oohashi; Yoshihiro Uno; Motoyuki Ishiguro

To evaluate the ability of low-dose dobutamine and isosorbite dinitrate (ISDN) gated blood pool scintigraphy (GBPS) and thallium SPECT with reinjection to identify viability in asynergic myocardium, both procedures were performed in 38 consecutive patients with chronic coronary artery disease and left ventricular dysfunction. Twenty-two of the 38 patients with successful revascularization were analyzed. GBPS was performed at the baseline and during continuous infusion of low dose dobutamine (5 μg/kg/min) and ISDN (2 μg/kg/min). Cine mode GBPS wall motion was scored from normal (0) to dyskinesis (4) semiquantitatively. Forty-seven of 110 segments with severe asynergy at the baseline were analyzed. Viability determined by GBPS was defined as wall motion score improvement by more than 1 grade. Thallium viability was defined as the segment with redistribution or fill in with severe initial perfusion defect. GBPS was 76.7% sensitive and 70.6% specific for predicting post vascularization wall motion improvement (p < 0.005). Of 47 segments with severe asynergy, concordance of judgement was obtained in 40 segments (85.1 %), and reversibility was correctly diagnosed in 34 of 40 patients (85.0%), but thallium with reinjection correctly identified tissue viability in 6 of 7 segments with discordance between 2 studies.These data suggest that most cases of reversible asynergy (hibernating myocardium) respond to ISDN and dobutamine, suggesting the possibility of predicting improvement by revascularization, although some underestimation of tissue viability remained to be resolved. Thallium with reinjection is superior to low-dose dobutamine + ISDN GBPS for the assessment of myocardial viability.


Catheterization and Cardiovascular Interventions | 2003

Myocardial perfusion during transient slow-flow in the patient with old vein graft intervention: assessment by serial measurement of pressure-derived fractional flow reserve and thermodilution-derived coronary flow reserve.

Hitoshi Matsuo; Sachiro Watanabe; Shinji Yasuda; Takeshi Hirose; Makoto Iwama; Shinichiro Tanaka; Takahiko Yamaki; Kouji Ono; Haruki Takahashi; Tomonori Segawa; Yukihiko Matsuno; Shinya Minatoguchi; Hisayoshi Fujiwara

A patient with distal slow‐flow after stenting in the old vein graft intervention was reported. This case is a first in whom guidewire‐based serial measurement of pressure‐derived fractional flow reserve (FFRmyo) and thermodilution‐based coronary flow reserve (CFRthermo) clearly demonstrated the serial change of microvascular circulation. During slow‐flow, CFRthermo remained in low value despite significant improvement of FFRmyo from 0.61 to 0.90. After thrombus aspiration and nicorandil injection, coronary flow reestablished immediately. CFRthermo improved significantly from 1.3 during slow‐flow to 3.6 after restoration of flow. Catheter Cardiovasc Interv 2003;60:392–398.


Circulation | 2002

Validation of Collateral Fractional Flow Reserve by Myocardial Perfusion Imaging

Hitoshi Matsuo; Sachiro Watanabe; Tohru Kadosaki; Takahiko Yamaki; Shinichiro Tanaka; Shuusaku Miyata; Tomonori Segawa; Yukihiko Matsuno; Masaaki Tomita; Hisayoshi Fujiwara


European Heart Journal | 2003

Evidence of pharmacologic preconditioning during PTCA by intravenous pretreatment with ATP-sensitive K+ channel opener nicorandil

Hitoshi Matsuo; Sachiro Watanabe; Tomonori Segawa; Shinji Yasuda; Takeshi Hirose; Makoto Iwama; Shinichiro Tanaka; Takahiko Yamaki; Yukihiko Matsuno; Masaaki Tomita; Shinya Minatoguchi; Hisayoshi Fujiwara


Japanese Circulation Journal-english Edition | 2004

FRS-175 Prevention of Peri-procedural Complication by Continuous Intracoronary Nicorandil Administration during PTCRA : Nicorandil versus Verapamil Prospective Randomized Trial(Percutaneous Coronary Intervention (IHD) : FRS21)(Featured Research Session (English))

Takeru Shiraki; Hitoshi Matsuo; Shunichiro Warita; Tai Kojima; Shinji Yasuda; Makoto Iwama; Takeshi Hirose; Shinichiro Tanaka; Takahiko Yamaki; Koji Ono; Haruki Takahashi; Tomonori Segawa; Yukihiko Matsuno; Sachiro Watanabe


Circulation | 2002

Evidence of a Cellular Protective Effect by Antecedent Angina Independent of Collateral Flow Recruitment During Coronary Angioplasty in Humans

Hitoshi Matsuo; Sachiro Watanabe; Tomonori Segawa; Takeshi Hirose; Makoto Iwama; Shinichiro Tanaka; Takahiko Yamaki; Shuusaku Miyata; Tohru Kadosaki; Yukihiko Matsuno; Masaaki Tomita; Shinya Minatoguchi; Hisayoshi Fujiwara


Journal of Japanese Society for Dialysis Therapy | 1991

Clinical significance of .ALPHA.-human atrial natriuretic peptide in patients on maintenance dialysis.

Hiroshige Ohashi; Hiroshi Oda; Yukihiko Matsuno; Sachiro Watanabe; Nobuyoshi Sugishita; Yasunori Kotoo; Katsumi Ueno; Akira Sugiyama; Kunihiro Okada; Tetsuo Matsubara; Hitoshi Matsuo; Masazumi Arai


Japanese Circulation Journal-english Edition | 2005

The Value and Limitation of IVUS and CAG for the Prediction of Slow/No Flow during and after PCI(Intravascular Endoscopy/Intravascular Ultrasound 3 (I), The 69th Annual Scientific Meeting of the Japanese Circulation Society)

Shunichiro Warita; Hitoshi Matsuo; Takatomo Watanabe; Tai Kojima; Takeru Shiraki; Takeshi Hirose; Makoto Iwama; Masahiko Kohda; Haruki Takahashi; Tomonori Segawa; Yukihiko Matsuno; Sachiro Watanabe

Collaboration


Dive into the Yukihiko Matsuno's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Hitoshi Matsuo

Wakayama Medical University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge